Background: The recent increase in the number and severity of cases of nosocomial
Clostridium difficile-associated diarrhea (CDAD) has prompted interest in the use of …

Background: Antibiotic treatment may disturb the resistance of gastrointestinal flora to
colonization. This may result in complications, the most serious of which is Clostridium …

Introduction Clostridium difficile infection (CDI) is the leading cause of antibiotic-associated
diarrhea. CDI has increased in incidence and severity over the past decade, and is a …

Objective Clostridium difficile‐associated diarrhea (CDAD) accounts for up to 25% of
patients with antibiotic‐associated diarrhea (AAD). We aimed to determine which probiotic is …

Objective: To review the literature on the use of probiotics to treat or prevent recurrences of
Clostridium difficile-associated diarrhea (CDAD) by replacing normal gastric flora. Data …

Meta-Analysis of Probiotics for the Prevention of Antibiotic... : Official journal of the American
College of Gastroenterology | ACG Meta-Analysis of Probiotics for the Prevention of Antibiotic …

Background Antibiotics can disturb gastrointestinal microbiota which may lead to reduced
resistance to pathogens such as Clostridium difficile (C. difficile). Probiotics are live …

Clostridium difficile infections are a global clinical concern and are one of the leading
causes of nosocomial outbreaks. Preventing these infections has benefited from …

The proportion and severity of Clostridium difficile-associated diarrhoea (CDAD) is
increasing in health-care settings. Antibiotics remain the most important risk factor for CDAD …

Despite advances in the diagnosis and treatment of Clostridium difficile infection (CDI) and
prevention efforts to reduce the spread of C. difficile, CDI remains a significant challenge to …